Hi sean, what do you think about TEKLA LIFE SCIENCES? Thanks.

Comments
No. 1-3
Sean Hyman
Sean Hyman

Editor

You're welcome.

Ling
Ling

Thank you.

Sean Hyman
Sean Hyman

Editor

It's a small closed-end biotech fund that's hard to get info on. It trades close to its NAV (Net Asset Value). Hard to quantify fundamentally and it sometimes has low trading volume. So I'd have no incentive to be in it. There are a couple of strong biotech stocks that are on my watch list. But biotechs are such tricky investments that I tend to like to see either deep value P/E wise or extreme pessimism weekly volume wise before going in. It's rare I'd make a biotech call, I'd imagine.

Stories